The Effect of Higher Level Computerized Clinical Decision Support Systems on Oncology Care: A Systematic Review

Abstract

Background: To deal with complexity in cancer care, computerized clinical decision support systems (CDSSs) are developed to support quality of care and improve decision-making. We performed a systematic review to explore the value of CDSSs using automated clinical guidelines, Artificial Intelligence, datamining or statistical methods (higher level CDSSs) on the quality of care in oncology. Materials and Methods: The search strategy combined synonyms for 'CDSS' and 'cancer.' Pubmed, Embase, The Cochrane Library, Institute of Electrical and Electronics Engineers, Association of Computing Machinery digital library and Web of Science were systematically searched from January 2000 to December 2019. Included studies evaluated the impact of higher level CDSSs on process outcomes, guideline adherence and clinical outcomes. Results: 11,397 studies were selected for screening, after which 61 full-text articles were assessed for eligibility. Finally, nine studies were included in the final analysis with a total population size of 7985 patients. Types of cancer included breast cancer (63.1%), lung cancer (27.8%), prostate cancer (4.1%), colorectal cancer (3.1%) and other cancer types (1.9%). The included studies demonstrated significant improvements of higher level CDSSs on process outcomes and guideline adherence across diverse settings in oncology. No significant differences were reported for clinical outcomes. Conclusion: Higher level CDSSs seem to improve process outcomes and guidelines adherence but not clinical outcomes. It should be noticed that the included studies primarily focused on breast and lung cancer. To further explore the impact of higher level CDSSs on quality of care, high-quality research is required.

Impact of Big Data Analytics on People’s Health: Overview of Systematic Reviews and Recommendations for Future Studies

“…Many reviews included data collected from electronic medical records, hospital information systems, or any databank that used individual patient data to create predictive models or evaluate collective patterns [12,13,[16][17][18][19][20][21][24][25][26][27]30,[33][34][35]37,38,40,[42][43][44][45]. Additionally, four reviews included primary studies based on imaging datasets and databanks, assessing different parameters of accuracy [15,29,31,36].…”

“…Most of the studies assessed the effects of big data analytics on noncommunicable diseases [12][13][14][15]17,21,22,24,27,31,32,34,36,38,[40][41][42][43][44]. Furthermore, three reviews covered mental health, associated with the indicator "suicide mortality rate" [19,25,45]; three studies were related to the indicator "probability of dying from any of cardiovascular, cancer, diabetes, or chronic renal disease" [16,18,20,28,29]; and two studies were related to the indicator "proportion of bloodstream infections due to antimicrobial-resistant organisms" [26,33].…”

Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives

“…Clinical decision support systems (CDSSs) are being developed to provide improvement in decision making. At this moment, reviews and systematic reviews give limited data on how ML and DL techniques could provide clinical application based on CDSSs in PCa oncological care [ 14 , 15 ]. Therefore, AI and ML are still being considered an area of development.…”

Barriers and Facilitators for Implementation of a Computerized Clinical Decision Support System in Lung Cancer Multidisciplinary Team Meetings—A Qualitative Assessment

“…In the past, several reviews evaluated the impact of clinical decision support systems (CDSSs) across a variety of clinical settings [ 8 , 9 , 10 , 11 , 12 ]. Some reported improvements in patient care processes, clinician’s workflows, health care costs, use of preventative medicine and adherence to guidelines or standards of medical practice [ 8 , 9 , 10 , 11 ]. Others found no effect or negative effects [ 10 , 11 , 12 ].…”